Tokyo Tape
Sign in
← Medipal Holdings

Quarterly report · Q3

7459.TEDINET S100SUGP
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥2.71T2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥3.36T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥2.57T2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥37.2bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥37.5bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥50.2bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥65.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥49.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥53.7bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥56.7bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥28.3bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥38.8bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥29.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥36.7bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥37.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥1.87Tat 2023-12-31Cons.Assets
Total assets¥1.71Tat 2023-03-31Cons.Assets
Total assets¥1.81Tat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥1.16Tat 2023-12-31Cons.Liabilities
Total liabilities¥1.02Tat 2023-03-31Cons.Liabilities
Net assets / equity¥712.6bnat 2023-12-31Cons.Net assets
Net assets / equity¥688.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥678.0bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥214.7bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥195.0bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥133.192023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.82023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥184.822022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥142.162022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.652022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥179.122022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥136.42022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio31.0%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio32.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥2.2bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥2.2bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥30m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥86.7bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥86.7bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥1m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥2.3bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue2023-04-01 → 2023-12-31¥883.0bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue external2023-04-01 → 2023-12-31¥882.8bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥231m
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentsegment profit2023-04-01 → 2023-12-31¥22.0bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥1.75T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.75T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥2.0bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥13.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥2.72T
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥2.71T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥2.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥37.2bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥7.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥7.0bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31¥44m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥56.2bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥56.2bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.2bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue2022-04-01 → 2022-12-31¥848.2bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue external2022-04-01 → 2022-12-31¥847.9bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥253m
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.1bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.67T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.66T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥16.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥2.57T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥2.57T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥7.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥37.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 385
ItemContextValueUnit
Gross profitCurrentYTDDuration186670000000JPY
Salaries and allowances sgaPrior1YTDDuration54424000000JPY
Salaries and allowances sgaCurrentYTDDuration60751000000JPY
Welfare expenses sgaPrior1YTDDuration9473000000JPY
Welfare expenses sgaCurrentYTDDuration10560000000JPY
Provision for bonuses sgaPrior1YTDDuration3332000000JPY
Provision for bonuses sgaCurrentYTDDuration3600000000JPY
Retirement benefit expenses sgaPrior1YTDDuration2210000000JPY
Retirement benefit expenses sgaCurrentYTDDuration2903000000JPY
Distribution expenses sgaPrior1YTDDuration14408000000JPY
Distribution expenses sgaCurrentYTDDuration15054000000JPY
Rents sgaPrior1YTDDuration3112000000JPY
Rents sgaCurrentYTDDuration3638000000JPY
Depreciation sgaPrior1YTDDuration9111000000JPY
Depreciation sgaCurrentYTDDuration10179000000JPY
Other sgaPrior1YTDDuration37096000000JPY
Other sgaCurrentYTDDuration42767000000JPY
Selling general and administrative expensesPrior1YTDDuration133169000000JPY
Selling general and administrative expensesCurrentYTDDuration149454000000JPY
Operating incomePrior1YTDDuration37531000000JPY
Operating incomeCurrentYTDDuration37215000000JPY
Interest income noiPrior1YTDDuration93000000JPY
Interest income noiCurrentYTDDuration19000000JPY
Dividends income noiPrior1YTDDuration2041000000JPY
Dividends income noiCurrentYTDDuration2157000000JPY
Research fee income noiPrior1YTDDuration6205000000JPY
Research fee income noiCurrentYTDDuration6430000000JPY
Real estate rent noiPrior1YTDDuration1494000000JPY
Real estate rent noiCurrentYTDDuration1658000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration2630000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration2670000000JPY
Other noiPrior1YTDDuration796000000JPY
Other noiCurrentYTDDuration1532000000JPY
Non operating incomePrior1YTDDuration13262000000JPY
Non operating incomeCurrentYTDDuration14469000000JPY
Interest expenses noePrior1YTDDuration20000000JPY
Interest expenses noeCurrentYTDDuration6000000JPY
Rent expenses on real estates noePrior1YTDDuration754000000JPY
Rent expenses on real estates noeCurrentYTDDuration870000000JPY
Loss on investments in partnership noePrior1YTDDuration7000000JPY
Loss on investments in partnership noeCurrentYTDDuration390000000JPY
Other noePrior1YTDDuration102000000JPY
Other noeCurrentYTDDuration176000000JPY
Non operating expensesPrior1YTDDuration884000000JPY
Non operating expensesCurrentYTDDuration1443000000JPY
Ordinary incomePrior1YTDDuration49908000000JPY
Ordinary incomeCurrentYTDDuration50240000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration48000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration2000000JPY
Gain on step acquisitions eiPrior1YTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass